Free tool
FAERS Monitor: Prezista
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 202895 or its brand name (Prezista, Darunavir). Reports on generic versions are filed under their own applications.
Reports
15,121
Serious
13,236
88% of reports
Hospitalization
4,661
Death reported
1,506
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- foetal exposure during pregnancy1,163
- drug interaction992
- pain891
- emotional distress813
- anxiety812
- anhedonia705
- chronic kidney disease572
- exposure during pregnancy571
- maternal exposure during pregnancy538
- death500
- diarrhoea500
- renal failure498
- acute kidney injury493
- virologic failure482
- drug ineffective440
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 21 |
| 2007 | 211 |
| 2008 | 395 |
| 2009 | 524 |
| 2010 | 535 |
| 2011 | 427 |
| 2012 | 646 |
| 2013 | 816 |
| 2014 | 878 |
| 2015 | 1,271 |
| 2016 | 1,295 |
| 2017 | 982 |
| 2018 | 1,200 |
| 2019 | 1,174 |
| 2020 | 1,304 |
| 2021 | 926 |
| 2022 | 853 |
| 2023 | 595 |
| 2024 | 522 |
| 2025 | 324 |
| 2026 | 222 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,038 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| virologic failureSignal | 482 | 136.8 | 124.8 | 59,067 |
| anhedoniaSignal | 705 | 38.3 | 35.6 | 24,928 |
| foetal exposure during pregnancySignal | 1,163 | 20.2 | 19.1 | 20,955 |
| exposure during pregnancySignal | 571 | 12.9 | 11.9 | 6,211 |
| chronic kidney diseaseSignal | 572 | 10.5 | 9.7 | 4,912 |
| emotional distressSignal | 813 | 9.4 | 8.8 | 6,086 |
| drug interactionSignal | 992 | 8.7 | 8.2 | 6,807 |
| maternal exposure during pregnancySignal | 538 | 8.4 | 7.8 | 3,515 |
| renal failureSignal | 498 | 5.2 | 4.8 | 1,705 |
| acute kidney injurySignal | 493 | 4.5 | 4.1 | 1,340 |
| anxietySignal | 812 | 4.0 | 3.7 | 1,826 |
| painSignal | 891 | 2.0 | 1.9 | 470 |
| diarrhoea | 500 | 1.1 | 1.0 | 3 |
| death | 500 | 0.8 | 0.7 | 24 |
| drug ineffective | 440 | 0.5 | 0.4 | 290 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.